Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir-exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network 057.

Osorio LE, Boechat MI, Mirochnick M, Kumwenda N, Kreitchmann R, Emel L, Pinto J, Joao E, Santos B, Swenson M, George K, Sato P, Mofenson L, Nielsen-Saines K; HIV Prevention Trials Network (HPTN) 057 Protocol Team.

Pediatr Infect Dis J. 2017 Feb;36(2):184-188. doi: 10.1097/INF.0000000000001386.

2.

An assessment of option B implementation for the prevention of mother to child transmission in Dschang, Cameroon: results from the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) cohort.

Altan AM, Taafo F, Fopa F, Buonomo E, Marazzi MC, Nielsen-Saines K, Orlando S, Scarcella P, Ciccacci F, Mancinelli S, Lio MM, Palombi L.

Pan Afr Med J. 2016 Mar 10;23:72. doi: 10.11604/pamj.2016.23.72.7958. eCollection 2016.

3.

HIV-free survival at 12-24 months in breastfed infants of HIV-infected women on antiretroviral treatment.

Chikhungu LC, Bispo S, Rollins N, Siegfried N, Newell ML.

Trop Med Int Health. 2016 Jul;21(7):820-8. doi: 10.1111/tmi.12710. Epub 2016 May 24. Review.

4.

Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.

Tweya H, Keiser O, Haas AD, Tenthani L, Phiri S, Egger M, Estill J.

AIDS. 2016 Mar 27;30(6):953-62. doi: 10.1097/QAD.0000000000001009.

5.

Antiretroviral therapy provided to HIV-infected Malawian women in a randomized trial diminishes the positive effects of lipid-based nutrient supplements on breast-milk B vitamins.

Allen LH, Hampel D, Shahab-Ferdows S, York ER, Adair LS, Flax VL, Tegha G, Chasela CS, Kamwendo D, Jamieson DJ, Bentley ME.

Am J Clin Nutr. 2015 Dec;102(6):1468-74. doi: 10.3945/ajcn.114.105106. Epub 2015 Nov 4.

6.

Elimination of Mother-To-Child Transmission of HIV Infection: The Drug Resource Enhancement against AIDS and Malnutrition Model.

Liotta G, Marazzi MC, Mothibi KE, Zimba I, Amangoua EE, Bonje EK, Bossiky BN, Robinson PA, Scarcella P, Musokotwane K, Palombi L, Germano P, Narciso P, de Luca A, Alumando E, Mamary SH, Magid NA, Guidotti G, Mancinelli S, Orlando S, Peroni M, Buonomo E, Nielsen-Saines K.

Int J Environ Res Public Health. 2015 Oct 21;12(10):13224-39. doi: 10.3390/ijerph121013224. Review.

7.

Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male Partners.

Hoffman RM, Jaycocks A, Vardavas R, Wagner G, Lake JE, Mindry D, Currier JS, Landovitz RJ.

J Infect Dis. 2015 Nov 15;212(10):1534-43. doi: 10.1093/infdis/jiv305. Epub 2015 Jun 19.

8.

Community-Based HIV-1 Early Diagnosis and Risk Behavior Analysis of Men Having Sex with Men in Hong Kong.

Liang J, Liu L, Cheung M, Lee MP, Wang H, Li CH, Chan CC, Nishiura K, Tang X, Tan Z, Peng J, Cheung KW, Yam WC, Chen Z.

PLoS One. 2015 Apr 27;10(4):e0125715. doi: 10.1371/journal.pone.0125715. eCollection 2015.

9.

Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis.

Ciaranello AL, Myer L, Kelly K, Christensen S, Daskilewicz K, Doherty K, Bekker LG, Hou T, Wood R, Francke JA, Wools-Kaloustian K, Freedberg KA, Walensky RP.

PLoS One. 2015 Mar 10;10(3):e0117751. doi: 10.1371/journal.pone.0117751. eCollection 2015.

10.

Dried plasma/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross-sectional study in rural Burundi.

Calcagno A, Motta I, Milia MG, Rostagno R, Simiele M, Libanore V, Fontana S, D'Avolio A, Ghisetti V, Di Perri G, Bonora S.

Br J Clin Pharmacol. 2015 May;79(5):801-8. doi: 10.1111/bcp.12544.

11.

Evaluation of a community health worker intervention and the World Health Organization's Option B versus Option A to improve antenatal care and PMTCT outcomes in Dar es Salaam, Tanzania: study protocol for a cluster-randomized controlled health systems implementation trial.

Sando D, Geldsetzer P, Magesa L, Lema IA, Machumi L, Mwanyika-Sando M, Li N, Spiegelman D, Mungure E, Siril H, Mujinja P, Naburi H, Chalamilla G, Kilewo C, Ekström AM, Fawzi WW, Bärnighausen TW.

Trials. 2014 Sep 15;15:359. doi: 10.1186/1745-6215-15-359.

12.

Partner testing, linkage to care, and HIV-free survival in a program to prevent parent-to-child transmission of HIV in the Highlands of Papua New Guinea.

Carmone A, Bomai K, Bongi W, Frank TD, Dalepa H, Loifa B, Kiromat M, Das S, Franke MF.

Glob Health Action. 2014 Aug 27;7:24995. doi: 10.3402/gha.v7.24995. eCollection 2014.

13.

Lessons learned while implementing an HIV/AIDS care and treatment program in rural Mozambique.

Moon TD, Burlison JR, Sidat M, Pires P, Silva W, Solis M, Rocha M, Arregui C, Manders EJ, Vergara AE, Vermund SH.

Retrovirology (Auckl). 2010 Apr 23;3:1-14.

14.

Individualizing the WHO HIV and infant feeding guidelines: optimal breastfeeding duration to maximize infant HIV-free survival.

Ciaranello AL, Leroy V, Rusibamayila A, Freedberg KA, Shapiro R, Engelsmann B, Lockman S, Kelly KA, Dabis F, Walensky RP.

AIDS. 2014 Jul;28 Suppl 3:S287-99. doi: 10.1097/QAD.0000000000000337.

15.
16.

Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania.

Ngarina M, Tarimo EA, Naburi H, Kilewo C, Mwanyika-Sando M, Chalamilla G, Biberfeld G, Ekstrom AM.

PLoS One. 2014 Jan 22;9(1):e85310. doi: 10.1371/journal.pone.0085310. eCollection 2014.

17.

The case for addressing primary resistance mutations to non-nucleoside reverse transcriptase inhibitors to treat children born from mothers living with HIV in sub-Saharan Africa.

Kébé K, Bélec L, Diop Ndiaye H, Bousso Gueye S, Abdallah Malick Diouara A, Ngom S, Rama Diagne Gueye N, Mbaye N, Signaté Sy H, Mboup S, Touré Kane C.

J Int AIDS Soc. 2014 Jan 16;17:18526. doi: 10.7448/IAS.17.1.18526. eCollection 2014.

18.

HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana.

Shapiro RL, Kitch D, Ogwu A, Hughes MD, Lockman S, Powis K, Souda S, Moffat C, Moyo S, McIntosh K, van Widenfelt E, Zwerski S, Mazhani L, Makhema J, Essex M.

AIDS. 2013 Jul 31;27(12):1911-20.

19.

Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants.

Dryden-Peterson S, Jayeoba O, Hughes MD, Jibril H, McIntosh K, Modise TA, Asmelash A, Powis KM, Essex M, Shapiro RL, Lockman S.

PLoS One. 2013 Sep 23;8(9):e74171. doi: 10.1371/journal.pone.0074171. eCollection 2013.

20.

Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery.

Giuliano M, Andreotti M, Liotta G, Jere H, Sagno JB, Maulidi M, Mancinelli S, Buonomo E, Scarcella P, Pirillo MF, Amici R, Ceffa S, Vella S, Palombi L, Marazzi MC.

PLoS One. 2013 Jul 19;8(7):e68950. doi: 10.1371/journal.pone.0068950. Print 2013.

Supplemental Content

Support Center